70 results
Page 3 of 4
6-K
EX-4.1
i4t3 xizj
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
gt6 mkkiy0c6tt10yxy
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
t1hcw3ek jqk7f
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
cm0ulrnra9fv1pwv36o7
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
0lhesao
10 Jul 19
Prospectus supplement
8:18am
F-3
71fekpy5tj6eondheez
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
wqe4ccf0v vj8n2rh
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
g0qiz2xsekbtaallbmk
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
y490xzyg5tgy9e3tzhk
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
oece5xcvfm1j3goqmtr
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
e7q7v84h6u2k59nm 77a
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
gxvz2
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
xavg15hc4x
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
5fqx274bmtlpq7
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
p0pdcg 6ci7q9
21 Nov 18
Current report (foreign)
4:09pm
6-K
EX-99.2
slgcnh
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
45g4 ynpywpbk
19 Nov 18
Agreement and Plan of Merger
4:34pm